Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Condition:   Advanced Esophageal Squamous Carcinoma
Intervention:   Drug: Apatinib
Sponsor:   The First Affiliated Hospital of Zhengzhou University
Recruiting - verified June 2017

http://ift.tt/2sPhk1A